Top Institutions in Ophthalmology and Endocrinology
Institutions leading in this area combine expertise in ophthalmology, diabetes research, and pharmacology, conducting large-scale clinical trials and observational studies to evaluate ocular outcomes in patients treated with GLP-1 RAs. They also emphasize multidisciplinary approaches integrating endocrinology and eye care.
-
#1
Joslin Diabetes Center
Boston, MA
Joslin is a world-renowned diabetes research and clinical care center with extensive expertise in diabetic retinopathy and systemic diabetes complications, leading numerous landmark studies on diabetes therapies and their ocular effects.
-
#2
Massachusetts Eye and Ear Infirmary
Boston, MA
As a leading ophthalmology hospital affiliated with Harvard Medical School, it specializes in retinal diseases and has contributed significantly to understanding diabetic eye disease and ocular side effects of systemic medications.
-
#3
Mayo Clinic
Rochester, MN
Mayo Clinic integrates multidisciplinary diabetes and eye care research, with strong clinical programs investigating the safety and efficacy of novel diabetes medications including GLP-1 RAs and their ocular impacts.
-
#4
University of California, San Francisco (UCSF) Medical Center
San Francisco, CA
UCSF is a leader in translational research on diabetic eye disease and systemic diabetes therapies, with active clinical trials assessing ocular safety profiles of emerging diabetes drugs including GLP-1 receptor agonists.
-
#5
Johns Hopkins University
Baltimore, MD
Johns Hopkins has a strong history of clinical research in diabetic eye disease and systemic diabetes management, contributing to understanding the ocular risks of novel diabetes therapies through rigorous clinical trials.
